Summary
Cencora, Inc. (formerly AmerisourceBergen Corporation) filed an 8-K on May 17, 2013, to report the classification of its Canadian subsidiary, AmerisourceBergen Canada Corporation (ABCC), as discontinued operations. This decision was made in March 2013 due to a challenging economic environment in the Canadian pharmaceutical distribution market, leading to a commitment to divest ABCC. The filing also includes extensive unaudited adjusted consolidated statements of operations and segment information for various historical periods, including fiscal year 2012 quarters and fiscal year 2013 quarters up to March 31, 2013. This supplementary financial data is provided to give investors a clearer view of the company's performance excluding the divested Canadian operations.
Key Highlights
- 1Cencora (then AmerisourceBergen) committed to divesting its Canadian subsidiary, AmerisourceBergen Canada Corporation (ABCC), in March 2013.
- 2The divestiture decision was driven by a challenging economic environment in Canadian pharmaceutical distribution.
- 3ABCC's operating results have been classified as discontinued operations for all periods presented in the Form 10-Q for the quarter ended March 31, 2013.
- 4The company is providing unaudited adjusted consolidated Statements of Operations for historical periods.
- 5Unaudited adjusted segment information for historical periods is also being provided.
- 6The provided financial exhibits cover periods from Q4 FY2011 through Q3 FY2013.